Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example

Journal of Substance Abuse Treatment

Volumn 56, Issue , 2015, Pages 23-33

  Hien, Denise A ^a,b   Campbell, Aimee N C ^b   Ruglass, Lesia M ^c   Saavedra, Lissette ^d   Mathews, Abigail G ^e   Kiriakos, Grace ^f   Morgan Lopez, Antonio ^d  

^a ADELPHI UNIVERSITY   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c CITY COLLEGE OF NEW YORK   (United States)

^d RTI INTERNATIONAL   (United States)

^e EMMES CORPORATION   (United States)

^f WRIGHT INSTITUTE   (United States)

Author keywords

Clinical trials; Co occurring disorders; PTSD; Statistical methods

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); FEMALE; GOLD STANDARD; HUMAN; MENTAL DISEASE; MULTICENTER STUDY (TOPIC); POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SUBSTANCE ABUSE; SUBSTANCE USE; ADULT; COGNITIVE THERAPY; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PROCEDURES; PSYCHIATRIC DIAGNOSIS; STANDARDS; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; UNITED STATES; WOMEN'S HEALTH;

ADULT; COGNITIVE THERAPY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MULTICENTER STUDIES AS TOPIC; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; UNITED STATES; WOMEN'S HEALTH;

EID: 84937727217     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.04.001     Document Type: Article

References (77)

1. Anderson M.L., Najavits L.M. Does seeking safety reduce PTSD symptoms in women receiving physical disability compensation?. Rehabilitation Psychology 2014, 59(3):349-353.
2. Angrist J.D., Imbens G.W., Rubin D.B. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 1996, 91(434):444-455.
3. Barkham M., Connell J., Stiles W.B., Miles J.N., Margison F., Evans C., et al. Dose-effect relations and responsive regulation of treatment duration: The good enough level. Journal of Consulting and Clinical Psychology 2006, 74(1):160.
4. Barkham M., Rees A., Stiles W.B., Shapiro D.A., Hardy G.E., Reynolds S. Dose-effect relations in time-limited psychotherapy for depression. Journal of Consulting and Clinical Psychology 1996, 64:927-935.
5. Campbell A.N., Nunes E.V., Matthews A.G., Stitzer M., Miele G.M., Polsky D., et al. Internet-delivered treatment for substance abuse: A multisite randomized controlled trial. The American Journal of Psychiatry 2014, 171:683-690.
6. Castle J.E. Maximizing research opportunities: Secondary data analysis. Journal of Neuroscience Nursing 2003, 35(5):287-290.
7. Clay R.A. The pitfalls of RCTs: More than one way to measure. Monitor on Psychology 2012, 41(8):52.
8. Coffman D.L., Caldwell L.L., Smith E.A. Introducing the at-risk average causal effect with application to HealthWise South Africa. Prevention Science 2012, [Advance online publication, PMCID: PMC3405190]. 10.1007/s11121-011-0271-0.
9. Coffman D.L., Zhong W. Assessing mediation using marginal structural models in the presence of confounding and moderation. Psychological Methods 2012, 17(4):642-664.
10. Cohen L.R., Field C., Campbell A.N.C., Hien D.A. Intimate partner violence outcomes in women with PTSD and substance use: A secondary analysis of NIDA clinical trials network "Women and Trauma" multi-site study. Addictive Behaviors 2013, 38(7):2325-2332.
11. Cohen L.R., Greenfield S.F., Gordon S., Killeen T., Jiang H., Zhang Y., et al. Survey of eating disorder symptoms among women in treatment for substance abuse. The American Journal on Addictions 2010, 19(3):245-251.
12. Collins L.M., Baker T.B., Mermelstein R.J., Piper M.E., Jorenby D.E., Smith S.S., et al. The multiphase optimization strategy for engineering effective tobacco use interventions. Annals of Behavioral Medicine 2011, 41:208-226. [PMCID: PMC3053423].
13. Coyer S.M., Gallo A.M. Secondary analysis of data. Journal of Pediatric Health Care 2005, 19(1):60-63.
14. Creamer M., Burgess P., McFarlane A.C. Post-traumatic stress disorder: Findings from the Australian National Survey of mental health and well-being. Psychological Medicine 2001, 31(7):1237-1247.
15. Curran P.J. The seemingly quixotic pursuit of a cumulative psychological science: Introduction to the special issue. Psychological Methods 2009, 14(2):77.
16. Curran P.J., Hussong A.M. Integrative data analysis: The simultaneous analysis of multiple data sets. Psychological Methods 2009, 14(2):81-100.
17. Debell F., Fear N.T., Head M., Batt-Rawden S., Greenberg N., Wessely S., et al. A systematic review of the comorbidity between PTSD and alcohol misuse. Social Psychiatry and Psychiatric Epidemiology 2009, 49(9):1401-1425.
18. Dong N. Causal moderation analysis using propensity score methods. Paper presented at the Spring 2012 Conference of the Society for Research on Educational Effectiveness (SREE), Washington, DC 2012, (ERIC #: ED530452).
19. Garmon Bibb S.C. Issues associated with secondary analysis of population health data. Applied Nursing Research 2007, 20(2):94-99.
20. Geller S.E., Koch A., Pellettieri B., Carnes M. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress?. Journal of Women's Health 2011, 20(3):315-320.
21. Gielen N., Krumeich A., Havermans R.C., Smeets F., Jansen A. Why clinicians do not implement integrated treatment for comorbid substance use disorder and posttraumatic stress disorder: A qualitative study. European Journal of Psychotraumatology 2014, 5:22821-22831.
22. Greenfield S.F., Brooks A.J., Gordon S.M., Green C.A., Kropp F., McHugh R.K., et al. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence 2007, 86(1):1-21.
23. Hamburg M.A., Collins F.S. The path to personalized medicine. New England Journal of Medicine 2010, 363(11):301-304.
24. Hien D.A., Campbell A.N.C., Killeen T., Hu M., Hansen C., Jiang H., et al. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA clinical trials network "Women and trauma" multi-site study. AIDS and Behavior 2010, 14(2):421-430.
25. Hien D.A., Campbell A.N.C., Ruglass L.M., Hu M., Killeen T. The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA's women and trauma study. Drug and Alcohol Dependence 2010, 111(1-2):114-119.
26. Hien D.A., Cohen L.R., Campbell A.N. Methodological innovation to increase the utility and efficiency of psychotherapy research for patients with co-occurring mental health and substance use disorders. Professional psychology: Research and practice 2009, 40(5):502.
27. Hien D.A., Jiang H., Campbell A.N.C., Hu M., Miele G.M., Cohen L.R., et al. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's clinical trials network. The American Journal of Psychiatry 2010, 167(1):95-101.
28. Hien D.A., Morgan-Lopez A., Campbell A.N.C., Saavedra L.M., Wu E., Cohen L., et al. Attendance and substance use outcomes for the Seeking Safety program: Sometimes less is more. Journal of Consulting and Clinical Psychology 2012, 80(1):29-42.
29. Hien D.A., Wells E.A., Jiang H., Suarez-Morales L., Campbell A.N.C., Cohen L.R., et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical Psychology 2009, 77(4):607-619.
30. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988, 75(4):800-802.
31. Hofferth S.L. Secondary data analysis in family research. Journal of Marriage and Family 2005, 67(4):891-907.
32. Hutchison K.E. Substance use disorders: Realizing the promise of pharmacogenomics and personalized medicine. Annual Review of Clinical Psychology 2010, 6:577-589.
33. Imai K., van Dyk D.A. Causal inference with general treatment regimes: Generalizing the propensity score. Journal of the American Statistical Association 2004, 99:854-866.
34. Jo B. Causal inference in randomized experiments with mediational processes. Psychological Methods 2008, 13(4):314-336.
35. Jo B., Stuart E.A. On the use of propensity scores in principal causal effect estimation. Statistics in Medicine 2009, 28(23):2857-2875.
36. Kazdin A.E. Mediators and mechanisms of change in psychotherapy research. Annual Review of Clinical Psychology 2007, 3:1-27.
37. Kazdin A.E. Evidence-based treatment and practice: New opportunities to bridge clinical research and practice, enhance the knowledge base, and improve patient care. American Psychologist 2008, 63(3):146-159.
38. Killeen T., Hien D., Campbell A., Brown C., Hansen C., Jiang H., et al. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. Journal of Substance Abuse Treatment 2008, 35(3):304-311.
39. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, National Academy Press, Washington, DC. S. Lamb, M.R. Greenlick, D. McCarty (Eds.).
40. Little R.J., Rubin D.B. Causal effects in clinical and epidemiological studies via potential outcomes: Concepts and analytical approaches. Annual Review of Public Health 2000, 21:121-145.
41. Lopez-Castro T., Hu M.C., Papini S., Ruglass L.M., Hien D.A. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring posttraumatic stress disorder and substance use disorders. Drug and Alcohol Review 2015, 10.1111/dar.12230.
42. López-Goñi J.J., Fernández-Montalvo J., Arteaga A. Addiction treatment dropout: Exploring patients' characteristics. The American Journal on Addictions 2012, 21(1):78-85.
43. MacDonald-Wilson K.L., Deegan P.E., Hutchison S.L., Parrotta N., Schuster J.M. Integrating personal medicine into service delivery: Empowering people in recovery. Psychiatric Rehabilitation Journal 2013, 36(4):258-263.
44. McCauley J.L., Killeen T., Gros D.F., Brady K.T., Back S.E. Posttraumatic stress disorder and co-occurring substance use disorders: Advances in assessment and treatment. Clinical Psychology: Science and Practice 2012, 9(3):283-304.
45. McClure E.A., Sonne S.C., Winhusen T., Carroll J.M., Ghitza U.E., McRae-Clark A.L., et al. Achieving Cannabis Cessation - Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemporary Clinical Trials 2014, 39(2):211-223.
46. McHugh R.K., Hu M., Campbell A.N.C., Hilario E.Y., Weiss R.D., Hien D.A. Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. Journal of Traumatic Stress 2014, 27(1):82-89.
47. McLellan A.T., Carise D., Kleber H.D. Can the national addiction treatment infrastructure support the public's demand for quality care?. Journal of Substance Abuse Treatment 2003, 25:117-121.
48. Miller S., Pagan D., Tross S. Women's health education 1998, [Unpublished manual].
49. Morgan-Lopez A., Fals-Stewart W. Analytic methods for modeling longitudinal data from rolling therapy groups with membership turnover. Journal of Consulting and Clinical Psychology 2007, 75(4):580-593.
50. Morgan-Lopez A., Saavedra L.M., Hien D.A., Campbell A.N., Wu E., Ruglass L. Synergy between seeking safety and twelve-step affiliation on substance use outcomes for women. Journal of Substance Abuse Treatment 2013, 45(2):179-189.
51. Morgan-Lopez A.A., Saavedra L.M., Hien D.A., Campbell A.N., Wu E., Ruglass L., et al. Indirect effects of 12-session seeking safety on substance use outcomes: Overall and attendance class-specific effects. The American Journal on Addictions 2014, 23(3):218-225.
52. Najavits L.M. Seeking safety: A treatment manual for PTSD and substance abuse 2002, Guilford Press, New York.
53. Nigel H. Methodological limitations of the RCT in determining the efficacy of psychological therapy for trauma. Journal of Traumatic Stress Disorders & Treatment 2012, 1(1):1-3.
54. Norman S.B., Myers U.S., Wilkins K.C., Goldsmith A.A., Hristova V., Huang Z., et al. Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder. Neuropharmacology 2012, 62(2):542-551.
55. Nunes E.V., Pavlicova M., Hu M.C., Campbell A.N., Miele G., Hien D., et al. Baseline matters: The importance of covariation for baseline severity in the analysis of clinical trials. The American Journal of Drug and Alcohol Abuse 2011, 37(5):446-452.
56. Onken L.S., Carroll K.M., Shoham V., Cuthbert B.N., Riddle M. Reenvisioning clinical science: Unifying the discipline to improve the public health. Clinical Psychological Science 2014, 2(1):22-34.
57. Ouimette P.C., Ahrens C., Moos R.H., Finney J.W. Posttraumatic stress disorder in substance abuse patients: Relationship to 1-year posttreatment outcomes. Psychology of Addictive Behaviors 1997, 11(1):34-47.
58. Pietrzak R.H., Goldstein R.B., Southwick S.M., Grant B.F. Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: Results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Anxiety Disorders 2011, 25(3):456-465.
59. Pinto R.M., Campbell A.N.C., Hien D.A., Yu G., Gorroochurn P. Retention in the national institute on drug abuse clinical trials network women and trauma study: Implications for posttrial implementation. American Journal of Orthopsychiatry 2011, 81(2):211-217.
60. Public Law 110-343 Mental Health Parity and Addiction Equity Act. 110th United States Congress 2008, US GPO, Washington, DC.
61. Public Law 111-148 Patient Protection and Affordable Care Act. 111th United States Congress 2010, US GPO, Washington, DC.
62. Resko S.M., Mendoza N.S. Early attrition from treatment among women with co-occurring substance use disorders and PTSD. Journal of Social Work Practice in the Addictions 2012, 12(4):348-369.
63. Rew L., Koniak-Griffin D., Lewis M.A., Miles M., O'Sullivan A. Secondary data analysis: New perspective for adolescent research. Nursing Outlook 2000, 48(5):223-229.
64. Robins J.M., Greenland S. Identifyiability and exchangeability for direct and indirect effects. Epidemiology 1992, 3(2):143-155.
65. Rogers E.M. Diffusion of innovations 2003, Free Press. 5th ed.
66. Ruglass L.M., Hien D.A., Hu M., Campbell A.N.C. Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: A secondary analysis of NIDA's women and trauma study. The American Journal on Addictions 2014, 23(1):90-95.
67. Ruglass L.M., Hien D.A., Hu M., Campbell A.N.C., Caldeira N.A., Miele G.M., et al. Racial/ethnic match and treatment outcomes for women with PTSD and substance use disorders receiving community-based treatment. Community Mental Health Journal 2014, 50(7):811-822.
68. Ruglass L.M., Miele G.M., Hien D.A., Campbell A.N.C., Hu M., Caldeira N., et al. Helping alliance, retention, and treatment outcomes: A secondary analysis from the NIDA clinical trials network women and trauma study. Substance Use & Misuse 2012, 47(6):695-707.
69. Smith E. Pitfalls and promises: The use of secondary data analysis in educational research. British Journal of Educational Studies 2008, 56(3):323-339.
70. Torchalla I., Nosen L., Rostam H., Allen P. Integrated treatment programs for individuals with concurrent substance use disorders and trauma experiences: A systematic review and meta-analysis. Journal of Substance Abuse Treatment 2012, 42(3):337.
71. van Dam D., Vedel E., Ehring T., Emmelkamp P.M.G. Psychological treatments for concurrent posttraumatic stress disorder and substance use disorder: A systematic review. Clinical Psychology Review 2012, 32(3):202-214.
72. Wampold B.E., Hollon S.D., Hill C.E. Unresolved questions and future directions in psychotherapy research. History of psychotherapy: Continuity and change 2011, 333-356. APA, Washington, DC. 2nd ed. J.C. Norcross, G.R. VandenBos, D.K. Freedheim (Eds.).
73. Westen D., Novotny C.M., Thompson-Brenner H. The empirical status of empirically supported psychotherapies: Assumptions, findings, and reporting in controlled clinical trials. Psychological Bulletin 2004, 130(4):631-663.
74. Windle P.E. Secondary data analysis: Is it useful and valid?. Journal of PeriAnesthesia Nursing 2010, 25(5):322-324.
75. Winhusen T., Winstanley E.L., Somoza E., Brigham G. The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Drug and Alcohol Dependence 2012, 120(1-3):225-228.
76. World Health Organization International guide for monitoring alcohol consumption and related harm. WHO/MSD/MSB/00.4 2000.
77. Zlotnick C., Johnson J., Najavits L.M. Randomized controlled pilot study cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behavior Therapy 2009, 40(4):325-336.